Gobert, Covid, Jim Forbes discussed on Bloomberg Businessweek


Possession is illegal. I'm Jim Forbes. Now this Bloomberg sports update, but Matt snapped their three game losing streak and defeat the Texas Rangers at Citi Field four to three, the big blow in the game for the nets of three run Homer by adorno Escobar in the fourth. All Texas starter and loser Glenn Otto, for Escobar a 7th Homer of the year, David Peterson made the start instead of Chris Bassett, Bassett placed on the COVID injury list. Peterson matched his career high for strikeouts in a game with ten, allowing three runs on 5 hits over 6 innings, raising his record to 5 and one, and when Diaz gets a 17th save. Before the game, the mets announced that Max Scherzer will be activated from the injured list, and will make the start Tuesday night in Cincinnati. The Yankee game against the Cleveland guardians postponed by rain, it will be made up as part of a split double header later today first game at 1210 second game at 6 ten. Day 5 at Wimbledon defending champion Novak Djokovic advanced to the fourth round with a straight set victory over Maya mere teck manovich, despite citing the ATP tour record for most career aces, John Isner, ousted bionic center. Americans, Jack sop, Tommy Paul and Francis TFO, all advanced. On the women's side, 121st ranked Brit, Heather Watson advances to the fourth round for the first time, while 5th seed, Maria sakari was eliminated by Tatiana Maria of Germany. American Allison risque lost to Marie busco. Third scene anz jaber advances to the fourth round and Elise mertens defeated Angelique Kerber in the only matchup of seated women's players on Friday. NBA news, the Utah Jazz have agreed to a blockbuster deal to trade all star center, Rudy Gobert to Minnesota. The deal with the Timberwolves sends 5 players to the jazz, along with four future first round draft picks. Gobert has spent his entire 9 year career with the jazz earning three defensive player of the year awards in that time. Last season, Gobert averaged roughly 15 points again. Will the Bloomberg sports update? I'm Tom Rogers. Broadcasting from the financial capital of the world. Bloomberg 11 three O in New York to Washington, D.C., Bloomberg 99 one to Boston, Bloomberg one O 6 one to San Francisco, Bloomberg 9 60 to the country. Syria's XM channel one 19 and around the globe, the Bloomberg business app in Bloomberg radio dot com. This is Bloomberg business week. So about two weeks ago, the Bloomberg noted that the U.S. cannabis market size expected to reach 40 billion by 2030 and expected to expand at a compound annual growth rate of nearly 15% over that time. That's a new report Tim that's app by grand view research, growth driven, at least this report said by increased legalization. Okay, so with this increased legalization, how are people who are using cannabis using it? Well, cure leaf just got some new data. They did this survey with Harris poll and it found that 91% of adults who are over the age of 21 who have ever consumed cannabis, they've actually done so for health and wellness purposes, Carol, as opposed to, well, you know, recreational, I would suppose. All right, so let's get to our guests with us. Is station woodcock? She is clinical cannabis pharmacist a curely joining us via Zoom in New York City. So tell us a little bit more about how people are using it because we do see growth in the industry. So tell us a bit more though about specifically where people are using it and for what reasons. Yeah, you know, I think this survey really helped clear up a lot of the stigma surrounding cannabis. People think that it's for escapism, for fun recreational purposes. But what we're really seeing is that by and large, the people that are consuming cannabis are doing so for help and wellness, it's for stress. It's for anxiety. It's for sleep. And the bigger takeaway is that over half of these people are using cannabis instead of pharmaceuticals. And I think one thing the COVID-19 pandemic did was sort of shift people towards more natural homeopathic sort of remedies and cannabis falls into that for a lot of people. How are they using it? Not what are they using it for? How are they using it? Are they eating edibles? Are they smoking it or are they? Yeah. I mean, I think that's the most fascinating fascinating thing about it. People think cannabis, they think smoking, smoking is actually bad for you, no matter what it is. So we see a lot of vaporization. And I think that's a good opportunity to remind people that we're talking about legal regulated products. So these are products that are sold through legal state markets. They're tested. They don't have pesticides. They don't have contaminants. There's nothing else in these vaporized products other than pure cannabis oil. And the terpenes found within the plant. That's really important because illicit market products are not regulated that way. We're seeing a lot of contaminated products. So these regulated products are much safer for people to consume, but we're also seeing the pharmaceutical industry technology brought into cannabis. So if you think of a traditional cannabis edible that takes like an hour to kick in and can last for 8 hours, we can change that with nano formulation that makes cannabis easier to be absorbed by the body so you can consume it in a beverage in a gummy formation. It's gonna work in like 15 minutes and only last for an hour or two. So people can really customize the products that they're using to the symptoms that they're looking for if you want to sleep all night. You can use something that's going to last all night. If you just need something for anxiety or stress right now, we have products for that too. So the versatility of the products really determines sort of what you're using them for. So tell me though, stasia, who should be using it because when you say homeopathic and I know there's been a lot moving forward in terms of greater oversight of homeopathic remedies. But I mean, I want transparency. I want to know what I'm kind of getting into. Yeah, absolutely. I think one of the things that we see a lot are people that are comfortable with the idea of cannabis for cancer, for multiple sclerosis, for Parkinson's disease. Like these really severe disease states. And there's a lack of understanding that it actually can be utilized for things like arthritis, or menstrual cramps for migraines, for stress for anxiety. I mean, we have patients and consumers coming in all the time for much simpler symptoms. And even more importantly, not all cannabis causes euphoria. I think that's also a huge misunderstanding that if you use cannabis, you're going to be stoned. That's absolutely not the case. The products come in a lot of different formulations, doses, ratios. So we can really customize what you're getting and how it's going to affect you for your lifestyle. But I guess what I wanted to go back to is remind me where we are in terms of FDA oversight of all of this. Yeah, there is no FDA oversight right now. It's all state by state regulated, but that's where that regulation comes into place. So the testing, the formulations, all of that is essentially pharmaceutical grade. Even without FDA oversight. Do we get to a point where there is that FDA oversight or we get to a point where, you know, I'm actually going to my primary care physician and she or he is recommending that I go to the pharmacy and pick up some cannabis, not going to a dispensary. Exactly. Yeah, I mean, that would require federal legalization and that's something I think the industry is definitely moving toward because access is huge. Like right now, someone who is a patient in New York say they can't travel to a different state legally with their medicine. And that's a problem. So we need that accessibility to open up. For people to be able to consume and have whatever they're using it for, to be able to cross state lines, have consistent product. You know, that's also something we're moving toward, but I think removing the stigma and seeing what people are using it for is a huge step in that direction. That stasia woodcock she's clinical cannabis pharmacist over a curate leaf. You're listening to Bloomberg businessweek, coming up, can you really, really get a stake by Bobby Flay from a food truck? The CEO of startup wonder explains how his company is putting Gourmet

Coming up next